NGMD.F Stock Overview
A specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
NuGen Medical Devices Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.067 |
| 52 Week High | CA$0.14 |
| 52 Week Low | CA$0.05 |
| Beta | 2.66 |
| 11 Month Change | -20.14% |
| 3 Month Change | -0.33% |
| 1 Year Change | -21.73% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -63.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| NGMD.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 8.7% | 0.8% | 0.5% |
| 1Y | -21.7% | 20.5% | 30.7% |
Return vs Industry: NGMD.F underperformed the US Medical Equipment industry which returned 20.5% over the past year.
Return vs Market: NGMD.F underperformed the US Market which returned 30.7% over the past year.
Price Volatility
| NGMD.F volatility | |
|---|---|
| NGMD.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NGMD.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine NGMD.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ian Heynen | www.nugenmd.com |
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. It also provides InsuJet system that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors.
NuGen Medical Devices Inc. Fundamentals Summary
| NGMD.F fundamental statistics | |
|---|---|
| Market cap | US$15.54m |
| Earnings (TTM) | -US$5.45m |
| Revenue (TTM) | US$247.44k |
62.8x
P/S Ratio-2.9x
P/E RatioIs NGMD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NGMD.F income statement (TTM) | |
|---|---|
| Revenue | CA$346.80k |
| Cost of Revenue | CA$176.35k |
| Gross Profit | CA$170.45k |
| Other Expenses | CA$7.80m |
| Earnings | -CA$7.63m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.035 |
| Gross Margin | 49.15% |
| Net Profit Margin | -2,201.33% |
| Debt/Equity Ratio | -221.0% |
How did NGMD.F perform over the long term?
See historical performance and comparison